Amino acids, lipid metabolites, and ferritin as potential mediators linking red meat consumption to type 2 diabetes

American Journal of Clinical Nutrition

Volumn 101, Issue 6, 2015, Pages 1241-1250

  Wittenbecher, Clemens ^a,b   Mühlenbruch, Kristin ^a,b   Kröger, Janine ^a,b   Jacobs, Simone ^a   Kuxhaus, Olga ^a,b   Floegel, Anna ^a   Fritsche, Andreas ^b,c   Pischon, Tobias ^d   Prehn, Cornelia ^e   Adamski, Jerzy ^b,e,f   Joost, Hans Georg ^a,b   Boeing, Heiner ^a   Schulze, Matthias B ^a,b  

^a GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Biomarkers; Cohort study; Metabolomics; Red meat; Type 2 diabetes mellitus

Indexed keywords

ACYLCARNITINE; AMINO ACID; ANTIHYPERTENSIVE AGENT; BIOLOGICAL MARKER; CARBOHYDRATE; CHOLESTEROL; DISACCHARIDE; FAT; FERRITIN; GLYCEROPHOSPHOLIPID; GLYCINE; IRON; LIPID; LYSOPHOSPHATIDYLCHOLINE; MONOSACCHARIDE; MONOUNSATURATED FATTY ACID; PHOSPHATIDYLCHOLINE; POLYUNSATURATED FATTY ACID; PROTEIN; SATURATED FATTY ACID; SPHINGOMYELIN;

ADULT; ARTICLE; BLOOD SAMPLING; BOOTSTRAPPING; CALORIC INTAKE; CASE CONTROL STUDY; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC PATIENT; DIETARY INTAKE; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; FOOD INTAKE; FOOD PROCESSING; HAZARD RATIO; HUMAN; HYPERTENSION; INCIDENCE; LIFESTYLE; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDIATOR; METABOLITE; METABOLOMICS; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROCESSED MEAT; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RED MEAT; RISK FACTOR; SERUM; ADVERSE EFFECTS; BLOOD; BODY MASS; CROSS-SECTIONAL STUDY; DIABETES MELLITUS, TYPE 2; DIET; FOLLOW UP; LIPID METABOLISM; MEAT; MULTICENTER STUDY (TOPIC); PHYSIOLOGY; REPRODUCIBILITY; STATISTICAL MODEL;

ADULT; AMINO ACIDS; BIOLOGICAL MARKERS; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIET; ENERGY INTAKE; FEMALE; FERRITINS; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LIFE STYLE; LINEAR MODELS; LIPID METABOLISM; MALE; MEAT; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RISK FACTORS;

EID: 84930429248     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.114.099150     Document Type: Article

References (49)

1. Feskens EJ, Sluik D, van Woudenbergh GJ. Meat consumption, diabetes, and its complications. Curr Diab Rep 2013;13:298-306.
2. Pan A, Sun Q, Bernstein AM, Schulze MB, Manson JE, Willett WC, Hu FB. Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. Am J Clin Nutr 2011;94:1088-96.
3. Benedinelli B, Palli D, Masala G, Sharp SJ, Schulze MB, Guevara M, van der AD, Sera F, Amiano P, et al. Association between dietary meat consumption and incident type 2 diabetes: the EPIC-InterAct study. Diabetologia 2013;56:47-59.
4. Pan A, Sun Q, Bernstein AM, Manson JE, Willett WC, Hu FB. Changes in red meat consumption and subsequent risk of type 2 diabetes mellitus: three cohorts of US men and women. JAMA Intern Med 2013;173:1328-35.
5. Mühlenbruch K, Ludwig T, Jeppesen C, Joost HG, Rathmann W, Meisinger C, Peters A, Boeing H, Thorand B, Schulze MB. Update of the German Diabetes Risk Score and external validation in the German MONICA/KORA study. Diabetes Res Clin Pract 2014;104:459-66.
6. Ley SH, Hamdy O, Mohan V, Hu FB. Prevention and management of type 2 diabetes: dietary components and nutritional strategies. Lancet 2014;383:1999-2007.
7. Montonen J, Boeing H, Fritsche A, Schleicher E, Joost HG, Schulze MB, Steffen A, Pischon T. Consumption of red meat and whole-grain bread in relation to biomarkers of obesity, inflammation, glucose metabolism and oxidative stress. Eur J Nutr 2013;52:337-45.
8. Ley SH, Sun Q, Willett WC, Eliassen AH, Wu K, Pan A, Grodstein F, Hu FB. Associations between red meat intake and biomarkers of inflammation and glucose metabolism in women. Am J Clin Nutr 2014;99:352-60.
9. Claus SP, Swann JR. Nutrimetabonomics: applications for nutritional sciences, with specific reference to gut microbial interactions. Annu Rev Food Sci Technol 2013;4:381-99.
10. Bictash M, Ebbels TM, Chan Q, Loo RL, Yap IK, Brown IJ, de Iorio M, Daviglus ML, Holmes E, Stamler J, et al. Opening up the "black box": metabolic phenotyping and metabolome-wide association studies in epidemiology. J Clin Epidemiol 2010;63:970-9.
11. Hu FB. Metabolic profiling of diabetes: from black-box epidemiology to systems epidemiology. Clin Chem 2011;57:1224-6.
12. Floegel A, Stefan N, Yu Z, Muhlenbruch K, Drogan D, Joost HG, Fritsche A, Haring HU, Hrabe de Angelis M, Peters A, et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 2013;62:639-48.
13. Montonen J, Boeing H, Steffen A, Lehmann R, Fritsche A, Joost HG, Schulze MB, Pischon T. Body iron stores and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Diabetologia 2012;55:2613-21.
14. Boeing H, Wahrendorf J, Becker N. EPIC-Germany - a source for studies into diet and risk of chronic diseases. Ann Nutr Metab 1999;43:195-204.
15. Boeing H, Korfmann A, Bergmann MM. Recruitment procedures of EPIC-Germany: European Investigation into Cancer and Nutrition. Ann Nutr Metab 1999;43:205-15.
16. Kroke A, Klipstein-Grobusch K, Voss S, Möseneder J, Thielecke F, Noack R, Boeing H. Validation of a self-administered food-frequency questionnaire administered in the European Prospective Investigation into Cancer and Nutrition (EPIC) study: comparison of energy, protein, and macronutrient intakes estimated with the doubly labeled water, urinary nitrogen, and repeated 24-h dietary recall methods. Am J Clin Nutr 1999;70:439-47.
17. Schienkiewitz A, Schulze MB, Hoffmann K, Kroke A, Boeing H. Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 2006;84:427-33.
18. Prentice RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986;73:1-11.
19. Stefan N, Fritsche A, Weikert C, Boeing H, Joost HG, Haring HU, Schulze MB. Plasma fetuin-A levels and the risk of type 2 diabetes. Diabetes 2008;57:2762-7.
20. Bohlscheid-Thomas S, Hoting I, Boeing H, Wahrendorf J. Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the German part of the EPIC project. European Prospective Investigation into Cancer and Nutrition. Int J Epidemiol 1997;26(Suppl 1):S59.
21. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997;65(Suppl):1220S-8S.
22. Römisch-Margl W, Prehn C, Bogumil R, Röhring C, Suhre K, Adamski J. Procedure for tissue sample preparation and metabolite extraction for high-throughput targeted metabolomics. Metabolomics 2012;8:133-42.
23. Floegel A, Drogan D, Wang-Sattler R, Prehn C, Illig T, Adamski J, Joost HG, Boeing H, Pischon T. Reliability of serum metabolite concentrations over a 4-month period using a targeted metabolomic approach. PLoS ONE 2011;6:e21103.
24. Montonen J, Drogan D, Joost HG, Boeing H, Fritsche A, Schleicher E, Schulze MB, Pischon T. Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes. Eur J Epidemiol 2011;26:29-38.
25. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173-82.
26. Prentice RL, Self SG. Aspects of the use of relative risk models in the design and analysis of cohort studies and prevention trials. Stat Med 1988;7:275-87.
27. Schulze MB, Hoffmann K, Kroke A, Boeing H. Dietary patterns and their association with food and nutrient intake in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study. Br J Nutr 2001;85:363-73.
28. Floegel A, von Ruesten A, Drogan D, Schulze MB, Prehn C, Adamski J, Pischon T, Boeing H. Variation of serum metabolites related to habitual diet: a targeted metabolomic approach in EPIC-Potsdam. Eur J Clin Nutr 2013;67:1100-8.
29. Floegel A, Wientzek A, Bachlechner U, Jacobs S, Drogan D, Prehn C, Adamski J, Krumsiek J, Schulze MB, Pischon T, et al. Linking diet, physical activity, cardiorespiratory fitness and obesity to serum metabolite networks: findings from a population-based study. Int J Obes (Lond) 2014;38:1388-96.
30. Benjamini Y, Hochberg Y. Controlling the false discovery rate - a practical and powerful approach to multiple testing. J R Stat Soc B 1995;57:289-300.
31. Hoffmann K, Pischon T, Schulz M, Schulze MB, Ray J, Boeing H. A statistical test for the equality of differently adjusted incidence rate ratios. Am J Epidemiol 2008;167:517-22.
32. Szklo M, Nieto FJ. Epidemiology: beyond the basics. Gaithersburg (MD): Aspen; 2000.
33. Williams P. Nutritional composition of red meat. Nutr Diet 2007;64(Suppl 4):S113-9.
34. Ye J. Mechanisms of insulin resistance in obesity. Front Med 2013;7:14-24.
35. Amati F. Revisiting the diacylglycerol-induced insulin resistance hypothesis. Obes Rev 2012;13(Suppl 2):40-50.
36. Kröger J, Zietemann V, Enzenbach C, Weikert C, Jansen EH, Doring F, Joost HG, Boeing H, Schulze MB. Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 2011;93:127-42.
37. Xu J, Yang S, Cai S, Dong J, Li X, Chen Z. Identification of biochemical changes in lactovegetarian urine using 1H NMR spectroscopy and pattern recognition. Anal Bioanal Chem 2010;396:1451-63.
38. O'Sullivan A, Gibney MJ, Brennan L. Dietary intake patterns are reflected in metabolomic profiles: potential role in dietary assessment studies. Am J Clin Nutr 2011;93:314-21.
39. Altorf-van der Kuil W, Brink EJ, Boetje M, Siebelink E, Bijlsma S, Engberink MF, van 't Veer P, Tome D, Bakker SJ, van Baak MA, et al. Identification of biomarkers for intake of protein from meat, dairy products and grains: a controlled dietary intervention study. Br J Nutr 2013;110:810-22.
40. Wang W, Wu Z, Dai Z, Yang Y, Wang J, Wu G. Glycine metabolism in animals and humans: implications for nutrition and health. Amino Acids 2013;45:463-77.
41. Wang-Sattler R, Yu Z, Herder C, Messias AC, Floegel A, He Y, Heim K, Campillos M, Holzapfel C, Thorand B, et al. Novel biomarkers for pre-diabetes identified by metabolomics. Mol Syst Biol 2012;8:615.
42. Xie W, Wood AR, Lyssenko V, Weedon MN, Knowles JW, Alkayyali S, Assimes TL, Quertermous T, Abbasi F, Paananen J, et al. Genetic variants associated with glycine metabolism and their role in insulin sensitivity and type 2 diabetes. Diabetes 2013;62:2141-50.
43. Wells AM, Haub MD, Fluckey J, Williams DK, Chernoff R, Campbell WW. Comparisons of vegetarian and beef-containing diets on hematological indexes and iron stores during a period of resistive training in older men. J Am Diet Assoc 2003;103:594-601.
44. Simcox JA, McClain DA. Iron and diabetes risk. Cell Metab 2013;17:329-41.
45. Hafeman DM. "Proportion explained": a causal interpretation for standard measures of indirect effect? Am J Epidemiol 2009;170:1443-8.
46. Pearl J. Causal Inference. Int J Biostat 2010;6:7-58.
47. Gelman A, Loken E. The statistical crisis in science. Am Sci 2014;102:460-5.
48. Krug S, Kastenmuller G, Stuckler F, Rist MJ, Skurk T, Sailer M, Raffler J, Romisch-Margl W, Adamski J, Prehn C, et al. The dynamic range of the human metabolome revealed by challenges. FASEB J 2012;26:2607-19.
49. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia (PA): Lippincott, Williams & Wilkins; 2008.